Astrazeneca (AZN) Research & Development (2009 - 2026)
Astrazeneca's Research & Development came in at -$4.05 billion for Q2 2026, compared with -$3.55 billion a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Research & Development (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Research & Development of -$25.44 billion; for FY2025, it was -$14.23 billion.
- Going back by year, Research & Development was -$13.58 billion in FY2024, -$10.94 billion in FY2023, -$9.76 billion in FY2022 and -$9.74 billion in FY2021.
- The five-year range for quarterly Research & Development is -$14.23 billion (Q4 2025) to -$2.13 billion (Q1 2022).
- Business Quant data shows AZN's Research & Development at -$3.49 billion (Q1 2026), -$14.23 billion (Q4 2025) and -$3.66 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 2.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.05 Bn |
| Mar 31, 2026 | -3.49 Bn |
| Dec 31, 2025 | -14.23 Bn |
| Sep 30, 2025 | -3.66 Bn |
| Jun 30, 2025 | -3.55 Bn |
| Mar 31, 2025 | -3.16 Bn |
| Dec 31, 2024 | -4.68 Bn |
| Sep 30, 2024 | -3.12 Bn |
| Jun 30, 2024 | -3.01 Bn |
| Mar 31, 2024 | -2.78 Bn |
| Dec 31, 2023 | -3.07 Bn |
| Sep 30, 2023 | -2.58 Bn |
| Jun 30, 2023 | -2.67 Bn |
| Mar 31, 2023 | -2.61 Bn |
| Dec 31, 2022 | -2.63 Bn |
| Sep 30, 2022 | -2.46 Bn |
| Jun 30, 2022 | -2.55 Bn |
| Mar 31, 2022 | -2.13 Bn |
| Dec 31, 2021 | -2.58 Bn |
| Sep 30, 2021 | -3.61 Bn |
API Access
Astrazeneca Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();